| Characteristic | PZA-sensitive cases (%) | PZA-resistant cases (%) | x2 | P value | |
| Gender | Male | 100 (67.6) | 24 (52.2) | 3.606 | 0.067 |
| Female | 48 (32.4) | 22 (47.8) | |||
| Medical history | Initial treatmenta | 113 (76.4) | 36 (78.3) | 0.072 | 0.978 |
| Retreatmentb | 35 (23.6) | 10 (21.7) | |||
| Age (years) | ≤25 | 44 (29.7) | 17 (37.0) | 3.892 | 0.273 |
| 25 - 44 | 53 (35.8) | 20 (43.5) | |||
| 45 - 64 | 35 (23.7) | 6 (13.0) | |||
| ≥65 | 16 (10.8) | 3 (6.5) | |||
| Sputum smear | 1+ | 52 (35.1) | 17 (37.0) | 0.665 | 0.721 |
| 2+ | 45 (30.4) | 16 (34.8) | |||
| ≥3+ | 51 (34.5) | 13 (28.2) | |||
| Lesions of infection | 1 - 2 | 28 (18.9) | 9 (19.6) | 3.907 | 0.142 |
| 3 - 4 | 40 (27.0) | 19 (41.3) | |||
| 5 - 6 | 80 (54.1) | 18 (39.1) | |||
| Cavitary lesions | 126 (85.1) | 37 (80.4) | 0.577 | 0.447 | |